The association between treatment-resistant depression and uncommon functional genetic alleles.
Wave rides new Phase 2 DMD data as it sets sights on accelerated approval
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS